GOLDMAN SACHS GROUP INC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 33 filers reported holding ETON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$189,185
-57.6%
57,503
-51.6%
0.00%
Q1 2024$445,706
+316.7%
118,855
+363.4%
0.00%
Q3 2023$106,961
+38.9%
25,650
+45.7%
0.00%
Q1 2022$77,000
-25.2%
17,610
-13.9%
0.00%
Q3 2021$103,00020,4460.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,529,887$11,080,9052.95%
Acuitas Investments, LLC 492,054$2,155,1971.12%
Westside Investment Management, Inc. 563,110$2,466,4240.63%
Parkman Healthcare Partners LLC 199,168$872,3560.12%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,314,0000.07%
ESSEX INVESTMENT MANAGEMENT CO LLC 78,613$344,3250.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 253,362$1,109,7260.02%
XTX Topco Ltd 22,858$100,1180.02%
Quantum Private Wealth, LLC 11,500$50,3700.02%
CHICAGO TRUST Co NA 16,700$73,1460.02%
View complete list of ETON PHARMACEUTICALS INC shareholders